RBC Capital maintains Linde at Outperform, raises price target to $568 from $549

RBC Capital raised its price target for Linde to $568 from $549, representing a 3.5% increase. This target suggests a 12.9% upside from Linde's Oct 29 close of $503.15. Recent analyst price targets for Linde range from $545 to $591.

Original reporting
Published Oct 30, 2026, 4:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 4:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RBC Capital maintains Linde at Outperform, raises price target to $568 from $549 — source image
Decision brief

The 30-second read

$LINBullishLow
01

Why it matters

Analyst upgrades often lead to short-term price appreciation, especially when the target increase is sizable.

02

Market read

The upgrade may generate modest buying interest in LIN and its peers.

03

What to watch

No new earnings or contract news; price move depends on broader market sentiment.

Relevance 5/10Novelty 5/10Timing: today

Background

RBC Capital's price target adjustment reflects its revised outlook for Linde's growth.

Company-level read

Ticker impact

$LINBullishMedium confidence
Context

RBC Capital raised its price target on Linde to $568 from $549, indicating a new bullish outlook.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

Target raise is a fresh analyst action; market may react but magnitude is limited.

Market effects

May lift sentiment for industrial gases sector.

Limited to markets tracking Linde and related peers.

Minor, confined to investors following analyst upgrades.

Counterpoint

Target raise could be premature if macro demand weakens.

Key entities

  • RBC Capital

    Equity research firm that raised Linde's price target.

  • Linde plc

    Industrial gases producer (ticker LIN).

Related articles

$LINMedAI 8/10

Linde PLC (LIN) (Q3 2026) Earnings Call Highlights: Record Sales, Profit and EPS

Linde PLC (LIN) reported Q3 2026 record sales, profit, and EPS, but faced challenges in non-gas segments like Lincare, which reduced EPS growth by 2%. Q4 EPS guidance is $4.40-$4.50, a 3% sequential decline due to FX headwinds and seasonality. Europe and China markets remain weak. Management is evaluating strategic options for Lincare and expects no near-term recovery in Europe or China. Electronics growth is strong, supported by $2B in projects.

$LINMed

Linde plc Q3 2026 Earnings Call Summary

Linde plc reported Q3 2026 earnings, including a $425M restructuring charge. Lincare was moved to the Global Other segment. Chemicals and Energy grew 12%, Electronics 15%. Q4 EPS guidance is $4.40-$4.50. Management expects restructuring benefits by H2 2027 and Woodside ammonia project completion by H1 2027.

$LINMedAI 8/10

Linde Q3 Earnings Call Highlights

Linde (LIN) reported varied demand across regions and sectors in Q3, with electronics sales up 15% and chemicals/energy up 12%. U.S. packaged-gas growth remained in the low teens, while Europe saw flat market conditions. Linde's project backlog is near $8 billion, with the Woodside project expected to contribute financially in 2024. The company forecasted Q4 EPS of $4.40-$4.50, with full-year EPS at $17.82-$17.92.

$LINHighAI 8/10

Linde delivers a good quarter and puts in a fix for an overhang on the stock

Linde reported record Q3 revenue of $9.4B, up 9.2%, and adjusted EPS of $4.59, beating estimates. Shares fell 1% despite strong results due to light Q4 guidance. CEO addressed Lincare restructuring, taking a $425M charge. Sales grew in electronics, chemicals, and energy, with space propellant demand noted. Full-year EPS outlook raised to $17.87, in line with consensus. Linde maintains a $550 price target.